CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Journey Through the Highlights of the 12th Annual Cancer Immunotherapy Month™ 

    Each June, CRI invites its global community of scientists, caretakers, patients, and more to take part in…
    July 1, 2024| Max Mallet
  • What’s in Your Glass? Weighing the Health Risks of Alcohol Consumption

    “Just one for the road.” We’ve all heard or said this at a party. Alcohol is a…
    June 28, 2024| Ajit Muley, PhD
  • CRI’s 5th Annual Wear White Luncheon Raises Over $40,000

    On Thursday, June 20, 2024, the Cancer Research Institute (CRI) celebrated its fifth annual Wear White Luncheon,…
    June 25, 2024| CRI Staff
  • Keytruda Receives 40th FDA Approval

    This week marked a significant milestone in the fight against cancer. On June 17, the FDA approved…
    June 21, 2024| Ajit Muley, PhD
  • Immunotherapy’s Visible Promise Against Head and Neck Cancer

    The drummer for the rock band Poison, Rikki Rockett, has made a name and a living for…
    April 4, 2024| Max Mallet
  • Can a simple blood test tell you how your cancer therapy works? 

    According to a recent study published in Nature Medicine, blood from patients can be used to screen…
    March 29, 2024| Ajit Muley, PhD
  • Exploring the Impact of Substance Use on Cancer Immunotherapy

    Alcohol and illicit drugs are common carcinogens that immunotherapy research is actively seeking to more thoroughly detail…
    March 22, 2024| Max Mallet
  • Dive into the Future of Immuno-Oncology with Our Experts in February’s IO Insights 

    The Cancer Research Institute (CRI) is thrilled to announce that the February issue of IO Insights is…
    March 13, 2024| Ajit Muley, PhD
  • Peggy Zuckerman is a Resilient Kidney Cancer Survivor and Here’s Why She is a Passionate Advocate for Awareness

    In 2004, North Dakota resident and educator Peggy Zuckerman was told by her doctor that she had…
    March 12, 2024| Max Mallet
Previous Page
1 … 5 6 7 8 9 … 20
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute